Pharmacogenetic markers of steroid dependent bronchial asthma (BA) control Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
The role of GSTT1 and GSTM1 in the risk of bronchial asthma (BA) formation in early kids, born by BA females Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Genetic variants in Protocadherin-1 , bronchial hyperresponsiveness and asthma subphenotypes in German children Source: Annual Congress 2012 - Asthma and the genes: from GWAS to next generation transcriptome analyses Year: 2012
New morphologic conception of allergic rhinitis (AR) and bronchial asthma (BA) Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009
Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001
The typing of cells in the induced sputum (IS) and its apoptosis in patients with bronchial asthma (BA) Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Comparative characteristics of regulatory T cells populations between patients with bronchial asthma (BA) and COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011
Correlation between score of Asthma Control Test (ACT) and airway hyperresponsiveness (AHR) in young adults with bronchial asthma (BA) Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006
Hypertrophic and polyposis synonasal mucosa (SM) changes in children with atopic bronchial asthma (BA) and allergic rhinitis (AR) Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
Association between house dust mites (HDM) number in homes and of α1–acid glycoprotein (α1-AGP) level in expired air condensate (EAC) and nasal lavage fluid (NLF) of children with bronchial asthma (BA) and allergic rhinitis (AR) Source: Eur Respir J 2005; 26: Suppl. 49, 693s Year: 2005
Quantitative CT-estimation of total and regional lung inflation in patients with bronchial asthma (BA) Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging Year: 2012
Bronchial asthma (BA): the reality Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001
The genetic markers (HLA system) of steroid-resistance in severe bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Genetic variants in the renin-angiotensin-system (RAS) in patients with bronchial hyperresponsiveness (BHR) Source: Eur Respir J 2001; 18: Suppl. 33, 429s Year: 2001
Omalizumab therapy of the children with uncontolled atopic bronchial asthma (BA) Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
Genetic and environmental interaction in allergy and asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007
Pharma-epidemiology of bronchial asthma (BA) in Russia. The results of the program ²BASIS². Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics Source: Eur Respir J 2001; 17: 59-63 Year: 2001
The contents of α1-acid glycoprotein (α1-AGP) and metabolites of nitric oxide (NO) in nasal lavage fluid (NLF) of patients with bronchial asthma (BA) and allergic rhinitis (AR) and house dust mites (HDM) exposure Source: Eur Respir J 2001; 18: Suppl. 33, 43s Year: 2001